Skip to main content
Katherine Cahill, MD, Allergy & Immunology, Nashville, TN

Katherine N Cahill MD

Asthma & Allergic Conditions


Medical Director of Asthma Clinical Research

Join to View Full Profile
  • 2611 West End AveSte 210Nashville, TN 37203

  • Phone+1 615-936-2727

Dr. Cahill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Allergy and Immunology, 2010 - 2013
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2007 - 2010
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 2007

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2018 - 2025
  • AL State Medical License
    AL State Medical License 2020 - 2020
  • MA State Medical License
    MA State Medical License 2012 - 2019
  • Allergy & Immunology
    American Board of Allergy and Immunology Allergy & Immunology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Original Article A One-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease  
    Tanya Laidlaw, Geneva A DeGregorio, Katherine N Cahill, ScienceDirect
  • Allergic Inflammatory Memory in Human Respiratory Epithelial Progenitor Cells  
    Nora A Barrett, Tanya M Laidlaw, Daniel F Dwyer, Joshua A Boyce, Neil Bhattacharyya, Kathleen M Buchheit, Katherine N Cahill, Nature

Press Mentions

  • Metformin Use Linked to Fewer Asthma Attacks
    Metformin Use Linked to Fewer Asthma AttacksNovember 19th, 2024
  • Diabetes Drug May Improve Asthma
    Diabetes Drug May Improve AsthmaFebruary 21st, 2023
  • Clinical Trial at VUMC Tests Novel Treatment for Asthma
    Clinical Trial at VUMC Tests Novel Treatment for AsthmaNovember 10th, 2022
  • Join now to see all

Grant Support

  • GLP-1R agonist immune targets in lean and obesity-associated asthmaVANDERBILT UNIVERSITY MEDICAL CENTER2024–2029
  • GLP-1R agonist immune targets in lean and obesity-associated asthmaVANDERBILT UNIVERSITY MEDICAL CENTER2024–2029
  • Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic AsthmaVANDERBILT UNIVERSITY MEDICAL CENTER2021–2026
  • K23 Career Development GrantNational Institute of Allergy and Infectious Disases2015–2020

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: